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Commentary
Deterioration of renal function is a much feared and all too frequent complication in patients undergoing procedures and investigations requiring the administration of iodinated contrast agents. Individuals with diabetes and/or pre-existing renal insuf ciency are at particularly high risk of developing nephrotoxicity. This well-designed, elegant trial by Kay et al examined whether the administration of acetylcysteine in patients with moderate stable renal impairment who undergo coronary angiography prevents contrastrelated acute nephropathy. Their results indicate that acetylcysteine affords a two-thirds reduction in the risk of signi cant renal deterioration and modestly shortens the length of hospitalization.
Unfortunately, the rather stringent exclusion criteria of this study may limit the applicability of these data to other high-risk groups of patients. In particular, patients with gradually declining renal function, those with acute renal failure, known congestive heart failure, LV ejection fraction ,35%, chronic obstructive lung disease or asthma were not studied. Moreover, as the authors themselves point out, less than 5% of the patients enrolled had serum creatinine levels above 2.5 mg/dl (221 mmol/l). Therefore, this study does not answer the question of whether or not acetylcysteine prevents contrast nephropathy and the need for dialysis in those with more advanced degrees of renal insuf ciency.
These caveats aside, this study adds to the growing body of evidence supporting the use of acetylcysteine to preserve renal function following exposure to radiographic contrast agents. 1 Therefore, administration of several doses of acetylcysteine before and after the use of contrast, in addition to intravenous hydration with saline 2 and the selection of low-3 or iso osmolar 4 nonionic contrast media, 5 should be recommended as the standard of care for patients at high risk of developing contrast nephrotoxicity who undergo these procedures.
Vascular viewpoint rating:
· Randomized -small · Quality -high · Is the primary conclusion valid? Most likely.
